Aprepitant: drug-drug interactions in perspectiveAAPRO, M. S; WALKO, C. M.Annals of oncology. 2010, Vol 21, Num 12, pp 2316-2323, issn 0923-7534, 8 p.Article

New antiemetic drugsROILA, F; FATIGONI, S.Annals of oncology. 2006, Vol 17, issn 0923-7534, ii96-ii100, SUP2Conference Paper

Characterization of a robust anti-Prelog short-chain dehydrogenase/reductase ChKRED20 from Chryseobacterium sp. CA49TANG, Tuo-Xian; YAN LIU; WU, Zhong-Liu et al.Journal of molecular catalysis. B, Enzymatic. 2014, Vol 105, pp 82-88, issn 1381-1177, 7 p.Article

Topical Aprepitant in Clinical and Experimental PruritusWALLENGREN, Joanna.Archives of dermatology (1960). 2012, Vol 148, Num 8, pp 957-959, issn 0003-987X, 3 p.Article

Aprepitant in antiemetic combinations to prevent chemotherapy-induced nausea and vomitingOLVER, I. N.International journal of clinical practice (Esher). 2004, Vol 58, Num 2, pp 201-206, issn 1368-5031, 6 p.Article

Identification of ketone reductase ChKRED20 from the genome of Chryseobacterium sp. CA49 for highly efficient anti-Prelog reduction of 3,5-bis(trilfuoromethyl )acetophenoneYAN LIU; TANG, Tuo-Xian; PEI, Xiao-Qiong et al.Journal of molecular catalysis. B, Enzymatic. 2014, Vol 102, pp 1-8, issn 1381-1177, 8 p.Article

Population pharmacokinetics of aprepitant and dexamethasone in the prevention of chemotherapy-induced nausea and vomitingNAKADE, Susumu; OHNO, Tomoya; KITAGAWA, Junsaku et al.Cancer chemotherapy and pharmacology. 2008, Vol 63, Num 1, pp 75-83, issn 0344-5704, 9 p.Article

Lack of Effect of Aprepitant or Its Prodrug Fosaprepitant on QTc Intervals in Healthy SubjectsMARBURY, Thomas C; BO JIN; PANEBIANCO, Deborah et al.Anesthesia and analgesia. 2009, Vol 109, Num 2, pp 418-425, issn 0003-2999, 8 p.Article

Update and new trends in antiemetic therapy: the continuing need for novel therapiesFEYER, P; JORDAN, K.Annals of oncology. 2011, Vol 22, Num 1, pp 30-38, issn 0923-7534, 9 p.Article

Neurokinin-1 receptor antagonists in the prevention of postoperative nausea and vomitingDIEMUNSCH, P; JOSHI, G. P; BRICHANT, J.-F et al.British journal of anaesthesia. 2009, Vol 103, Num 1, pp 7-13, issn 0007-0912, 7 p.Article

An HPLC chromatographic reactor approach for investigating the hydrolytic stability of a pharmaceutical compoundSKRDLA, Peter J; ABRAHIM, Ahmed; YAN WU et al.Journal of pharmaceutical and biomedical analysis. 2006, Vol 41, Num 3, pp 883-890, issn 0731-7085, 8 p.Article

Lack of effect of aprepitant on the pharmacokinetics of docetaxel in cancer patientsNYGREN, Peter; HANDE, Kenneth; GOTTESDIENER, Keith M et al.Cancer chemotherapy and pharmacology. 2005, Vol 55, Num 6, pp 609-616, issn 0344-5704, 8 p.Article

Effect of aprepitant on the pharmacokinetics and pharmacodynamics of warfarinDEPRE, M; VAN HECKEN, A; BERGMAN, A et al.European journal of clinical pharmacology. 2005, Vol 61, Num 5-6, pp 341-346, issn 0031-6970, 6 p.Article

No pharmacokinetic alteration of docetaxel following coadministration of aprepitant 3 h before docetaxel infusionKANETA, Toshikado; FUJITA, Ken-Ichi; AKIYAMA, Yuko et al.Cancer chemotherapy and pharmacology. 2014, Vol 74, Num 3, pp 539-547, issn 0344-5704, 9 p.Article

Detection of aprepitant drug based on low-dimensional un-doped iron oxide nanoparticles prepared by a solution methodRAHMAN, Mohammed M; BAHADAR KHAN, Sher; FAISAL, M et al.Electrochimica acta. 2012, Vol 75, pp 164-170, issn 0013-4686, 7 p.Article

Forecasting in vivo oral absorption and food effect of micronized and nanosized aprepitant formulations in humansSHONO, Yasushi; JANTRATID, Ekarat; KESISOGLOU, Filippos et al.European journal of pharmaceutics and biopharmaceutics. 2010, Vol 76, Num 1, pp 95-104, issn 0939-6411, 10 p.Article

A sensitive and rapid liquid chromatography-tandem mass spectrometry method for the quantification of the novel neurokinin-1 receptor antagonist aprepitant in rhesus macaque plasma, and cerebral spinal fluid, and human plasma with application in translational NeuroAIDs researchDI WU; PAUL, Dustin J; XIANGUO ZHAO et al.Journal of pharmaceutical and biomedical analysis. 2009, Vol 49, Num 3, pp 739-745, issn 0731-7085, 7 p.Article

Safety and efficacy of a triple antiemetic combination with the NK-1 antagonist aprepitant in highly and moderately emetogenic multiple-day chemotherapyJORDAN, Karin; KINITZ, Iris; VOIGT, Wieland et al.European journal of cancer (1990). 2009, Vol 45, Num 7, pp 1184-1187, issn 0959-8049, 4 p.Article

Aprepitant : A novel antiemetic for chemotherapy-induced nausea and vomitingMASSARO, Alison M; LENZ, Kristi L.The Annals of pharmacotherapy. 2005, Vol 39, Num 1, pp 77-85, issn 1060-0280, 9 p.Article

Aprepitant for the control of chemotherapy induced nausea and vomiting in adolescentsSMITH, Angela R; REPKA, Tanya L; WEIGEL, Brenda J et al.Pediatric blood & cancer. 2005, Vol 45, Num 6, pp 857-860, issn 1545-5009, 4 p.Article

Antiemesis After Total Joint Arthroplasty: Does a Single Preoperative Dose of Aprepitant Reduce Nausea and Vomiting? : Complications of hip arthroplastyDILORIO, Timothy M; SHARKEY, Peter F; HEWITT, Agnes M et al.Clinical orthopaedics and related research. 2010, Vol 468, Num 9, pp 2405-2409, issn 0009-921X, 5 p.Article

Human Positron emission tomography studies of Brain neurokinin 1 receptor occupancy by AprepitantBERGSTROM, Mats; HARGREAVES, Richard J; ESKOLA, Olli et al.Biological psychiatry (1969). 2004, Vol 55, Num 10, pp 1007-1012, issn 0006-3223, 6 p.Article

Efficacy of the neurokinin-1 receptor antagonist aprepitant in children with cyclical vomiting syndromeCRISTOFORI, F; THAPAR, N; SALIAKELLIS, E et al.Alimentary pharmacology & therapeutics. 2014, Vol 40, Num 3, pp 309-317, issn 0269-2813, 9 p.Article

A randomized, placebo-controlled, crossover, double-blind trial of the NK1 receptor antagonist aprepitant on gastrointestinal motor function in healthy humansMADSEN, J. L; FUGLSANG, S.Alimentary pharmacology & therapeutics. 2008, Vol 27, Num 7, pp 609-615, issn 0269-2813, 7 p.Article

Effect of impaired renal function and haemodialysis on the pharmacokinetics of aprepitantBERGMAN, Arthur J; MARBURY, Thomas; HUSKEY, Su-Er W et al.Clinical pharmacokinetics. 2005, Vol 44, Num 6, pp 637-647, issn 0312-5963, 11 p.Article